caa a22 4500 465752322 CHVBK 20180323111837.0 cr unu---uuuuu 170327e19900301xx s 000 0 eng 10.1007/BF01576275 doi (NATIONALLICENCE)springer-10.1007/BF01576275 Metastatic prostate cancer [Elektronische Daten] Hormonal treatment [William Nabors, E. Crawford] Summary: For decades the palliation of prostate cancer has centered around hormonal manipulation using orchiectomy or estrogen administration. Newer modalities, such as LHRH agonists and nonsteroidal antiandrogens, are now available. Patients receiving combination therapy enjoy superior progression-free and median survival rates. Springer-Verlag, 1990 Nabors William Division of Urology, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Campus Box C319, Denver, USA aut Crawford E. Division of Urology, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Campus Box C319, Denver, USA aut World Journal of Urology Springer-Verlag 8/1(1990-03-01), 34-39 0724-4983 8:1<34 1990 8 345 https://doi.org/10.1007/BF01576275 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF01576275 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Nabors William Division of Urology, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Campus Box C319, Denver, USA aut NATIONALLICENCE 700 1- Crawford E. Division of Urology, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Campus Box C319, Denver, USA aut NATIONALLICENCE 773 0- World Journal of Urology Springer-Verlag 8/1(1990-03-01), 34-39 0724-4983 8:1<34 1990 8 345 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer